State of Alaska Department of Revenue’s Krystal Biotech KRYS Stock Holding History

State of Alaska Department of Revenue’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.97M	Sell	13,385 -4,099	-23%	-$1.22M	0.05%	338
2026 Q1	$4.51M	Sell	17,484 -418	-2%	-$111K	0.05%	351
2025 Q4	$4.41M	Buy	17,902 +3,628	+25%	+$764K	0.05%	354
2025 Q3	$2.52M	Sell	14,274 -856	-6%	-$128K	0.03%	616
2025 Q2	$2.08M	Buy	15,130 +1,106	+8%	+$162K	0.02%	692
2025 Q1	$2.53M	Sell	14,024 -399	-3%	-$67.1K	0.03%	570
2024 Q4	$2.26M	Sell	14,423 -5	-0%	-$887	0.03%	645
2024 Q3	$2.63M	Sell	14,428 -159	-1%	-$30.7K	0.03%	615
2024 Q2	$2.68M	Buy	+14,587	New	+$2.45M	0.03%	585

Other funds holding KRYS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State of Alaska Department of Revenue's KRYS Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Krystal Biotech (KRYS) stake by 23% in Q2 2026, selling an estimated $1.22M and leaving 13,385 shares worth $4.97M. The position accounts for 0.05% of the portfolio, ranked #338.

State of Alaska Department of Revenue first reported a position in KRYS in Q2 2024 and has held it in 9 quarters since. 275 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

State of Alaska Department of Revenue held 13,385 shares of Krystal Biotech worth $4.97M as of Q2 2026.
State of Alaska Department of Revenue sold 4,099 Krystal Biotech shares in Q2 2026, an estimated $1.22M.
Krystal Biotech made up 0.05% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #338 holding.
State of Alaska Department of Revenue first reported a position in Krystal Biotech in Q2 2024 and has held it in 9 quarters since.
275 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.